Page 82 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 82

Bletilla  formosana  and  Its  Constituents  as  Promising  Therapeutics  via

               Modulation of Redox Homeostasis


               Po-Jen Chen*   ,1,2

               1  Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical
                 University, Kaohsiung 807378, Taiwan
               2   Graduate  Institute  of  Medicine,  College  of  Medicine,  Kaohsiung  Medical  University,
                 Kaohsiung 807378, Taiwan

               * E-mail: pjc@kmu.edu.tw

               Abstract
                  Redox homeostasis tightly regulates a variety of physiological processes essential for human
               health. Therefore, we are actively engaged in the development of drug candidates that target
               redox homeostasis as a therapeutic strategy for disease treatment. Bletilla formosana (Hayata)

               Schltr, a Taiwan native herbal medicine, exhibits anti-inflammatory and antioxidant activities.
               To facilitate the development of B. formosana-derived therapeutics, we focused on neutrophilic
               inflammatory disorders and cancers, which are closely associated with dysregulated oxidative
               stress.  Our  research  demonstrated  for  the  first  time  that  natural  products,  isolated  from  B.

               formosana, function as novel inhibitors of Src family kinases (SFKs) and potent free radical
               scavengers, effectively reducing neutrophilic oxidative stress-mediated lung and liver injury in
               mouse models. Furthermore, cancer as the leading cause of mortality in Taiwan, we identified
               benzyl and phenanthrene natural products from B. formosana as potent anticancer constituents

               using chemical molecular networking analysis. Among these, a benzyl compound emerged as
               a  lead  anticancer  compound,  exhibiting  oxidative  stress-dependent  or  microtubule-targeted
               mechanisms  in  cancer  cells  and  tumor-bearing  mice.  Together,  our  findings  highlight  B.
               formosana and its constituents as promising lead candidates for therapeutic intervention against

               neutrophilic  inflammatory  disorders  and  cancers.  Therapeutically  modulating  neutrophilic
               oxidative  stress  or  inducing  oxidative  stress-dependent  cytotoxicity  in  cancer  cells  offers
               promising strategies for managing inflammatory conditions and cancers.

               Keywords:  Bletilla  formosana;  Oxidative  stress;  Neutrophilic  inflammation;  Anticancer;
               natural products
















                                                           60
   77   78   79   80   81   82   83   84   85   86   87